Dr Lal PathLabs on Thursday said its consolidated profit after tax declined 7 per cent to ₹54 crore for the December quarter.
The company had reported a net profit of ₹58 crore in the October-December quarter of the previous fiscal.
Revenue also declined to ₹489 crore for the period under review as compared with ₹497 crore in the year-ago period, the company said in a regulatory filing.
Also read: Britannia’s Q3 net profit up 151% to ₹932 crore on one-time exceptional gain
"We continue to focus on geographical expansion and strengthen our presence in Tier 2, Tier 3 towns. Our focus continues to take a higher market share in West and South markets by leveraging technology and promoting high-end super specialty test portfolios," Dr Lal PathLabs Managing Director Om Manchanda said.
Shares of the company were trading 1.63 per cent down at ₹2,019.15 apiece on the BSE.